Agenus Inc. (AGEN) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agenus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.631 Good morning. My name is Audra, and I will be your conference operator today. 00:00:04.631 -- 00:00:08.133 At this time, I would like to welcome everyone to the Agilent Inc. 00:00:08.133 -- 00:00:12.855 fourth quarter and full year 2023 results conference call. 00:00:12.855 -- 00:00:17.157 Today's conference is being recorded. All lines have been placed on mute to prevent any 00:00:17.157 -- 00:00:21.879 background noise. After the speaker's remarks, there will be a question and answer session. 00:00:21.879 -- 00:00:25.380 If you would like to ask a question during this time, simply press the star key followed 00:00:25.380 -- 00:00:27.984 by the number one on your telephone keypad. 00:00:27.984 -- 00:00:31.706 If you would like to withdraw your question, press star 1 again. 00:00:31.706 -- 00:00:35.208 At this time, I would like to turn the conference over to Zach Arman, Head of Investor 00:00:35.208 -- 00:00:38.030 Relations. Please go ahead. 00:00:38.030 -- 00:00:41.572 Thank you, Audra, and thank you all for joining us today. 00:00:41.572 -- 00:00:46.755 Today's call is being webcast and will be available on our website for replay. 00:00:46.755 -- 00:00:50.837 I'd like to remind you that this call will include forward-looking statements, including 00:00:50.837 -- 00:00:56.112 statements regarding our clinical development, regulatory, and commercial plans and timelines. 00:00:56.112 -- 00:01:01.115 as well as timelines for data release and partnership opportunities, among other updates. 00:01:01.115 -- 00:01:06.178 These statements are subject to risks and uncertainties, and we refer you to our SEC 00:01:06.178 -- 00:01:10.801 filings available on our website for more details on these risks. 00:01:10.801 -- 00:01:15.463 Joining m...